128 related articles for article (PubMed ID: 2894999)
1. The pharmacological selectivity of three NMDA antagonists.
Childs AM; Evans RH; Watkins JC
Eur J Pharmacol; 1988 Jan; 145(1):81-6. PubMed ID: 2894999
[TBL] [Abstract][Full Text] [Related]
2. A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonists.
Lodge D; Davies SN; Jones MG; Millar J; Manallack DT; Ornstein PL; Verberne AJ; Young N; Beart PM
Br J Pharmacol; 1988 Nov; 95(3):957-65. PubMed ID: 2905186
[TBL] [Abstract][Full Text] [Related]
3. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model.
Stasheff SF; Anderson WW; Clark S; Wilson WA
Science; 1989 Aug; 245(4918):648-51. PubMed ID: 2569762
[TBL] [Abstract][Full Text] [Related]
4. Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801).
Lyle TA; Magill CA; Britcher SF; Denny GH; Thompson WJ; Murphy JS; Knight AR; Kemp JA; Marshall GR; Middlemiss DN
J Med Chem; 1990 Mar; 33(3):1047-52. PubMed ID: 2155319
[TBL] [Abstract][Full Text] [Related]
5. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
Foster AC; Wong EH
Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
[TBL] [Abstract][Full Text] [Related]
6. CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity.
Davies J; Evans RH; Herrling PL; Jones AW; Olverman HJ; Pook P; Watkins JC
Brain Res; 1986 Sep; 382(1):169-73. PubMed ID: 2876749
[TBL] [Abstract][Full Text] [Related]
7. Competitive and noncompetitive N-methyl-D-aspartate antagonists modify hypoxia-induced membrane potential changes and protect rat hippocampal slices from functional failure: a quantitative comparison.
Grigg JJ; Anderson EG
J Pharmacol Exp Ther; 1990 Apr; 253(1):130-5. PubMed ID: 1970359
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of N-methyl-D-aspartate evoked sodium flux by MK-801.
Ransom RW; Stec NL
Brain Res; 1988 Mar; 444(1):25-32. PubMed ID: 3282615
[TBL] [Abstract][Full Text] [Related]
9. Protection by NMDA antagonists against selective cell loss following transient ischaemia.
Swan JH; Meldrum BS
J Cereb Blood Flow Metab; 1990 May; 10(3):343-51. PubMed ID: 2158499
[TBL] [Abstract][Full Text] [Related]
10. A comparison of excitatory amino acid antagonists acting at primary afferent C fibres and motoneurones of the isolated spinal cord of the rat.
Evans RH; Evans SJ; Pook PC; Sunter DC
Br J Pharmacol; 1987 Jul; 91(3):531-7. PubMed ID: 3038242
[TBL] [Abstract][Full Text] [Related]
11. The N-methyl-D-aspartate antagonists aminophosphonovaleric acid and MK-801 reduce anoxic damage to dentate granule and CA1 pyramidal cells in the rat hippocampal slice.
Kass IS; Chambers G; Cottrell JE
Exp Neurol; 1989 Feb; 103(2):116-22. PubMed ID: 2563246
[TBL] [Abstract][Full Text] [Related]
12. Both competitive and non-competitive antagonists of N-methyl-D-aspartic acid disrupt brightness discrimination in rats.
Tang AH; Ho PM
Eur J Pharmacol; 1988 Jun; 151(1):143-6. PubMed ID: 3046954
[TBL] [Abstract][Full Text] [Related]
13. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
[TBL] [Abstract][Full Text] [Related]
14. Effects of antagonists on N-methyl-D-aspartate response in acutely isolated nucleus tractus solitarii neurons of the rat.
Nakagawa T; Shirasaki T; Tateishi N; Murase K; Akaike N
Neurosci Lett; 1990 May; 113(2):169-74. PubMed ID: 1974040
[TBL] [Abstract][Full Text] [Related]
15. Concentration-jump experiments with NMDA antagonists in mouse cultured hippocampal neurons.
Benveniste M; Mienville JM; Sernagor E; Mayer ML
J Neurophysiol; 1990 Jun; 63(6):1373-84. PubMed ID: 1972740
[TBL] [Abstract][Full Text] [Related]
16. The effects of N-methyl-D-aspartate antagonists on the development of vestibular compensation in the guinea pig.
Darlington CL; Smith PF
Eur J Pharmacol; 1989 Dec; 174(2-3):273-8. PubMed ID: 2698350
[TBL] [Abstract][Full Text] [Related]
17. NMDA antagonists and potentiation of NMDA-induced motoneuron depolarizations in the isolated frog spinal cord.
Zhang DX; Hackman JC; Davidoff RA
Brain Res; 1989 Jul; 493(1):129-35. PubMed ID: 2570616
[TBL] [Abstract][Full Text] [Related]
18. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
Koek W; Woods JH; Winger GD
J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
[TBL] [Abstract][Full Text] [Related]
19. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
[TBL] [Abstract][Full Text] [Related]
20. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
